vs
Ultragenyx Pharmaceutical Inc.（RARE）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Ribbon Communications Inc.的1.3倍（$207.3M vs $162.6M），Ribbon Communications Inc.净利率更高（54.8% vs -62.0%，领先116.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -10.3%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -8.1%）
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
RARE vs RBBN — 直观对比
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $207.3M | $162.6M |
| 净利润 | $-128.6M | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | -54.7% | 37.6% |
| 净利率 | -62.0% | 54.8% |
| 营收同比 | 25.9% | -10.3% |
| 净利润同比 | 3.5% | — |
| 每股收益（稀释后） | $-1.28 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | — | $162.6M | ||
| Q4 25 | $207.3M | $227.3M | ||
| Q3 25 | $159.9M | $215.4M | ||
| Q2 25 | $166.5M | $220.6M | ||
| Q1 25 | $139.3M | $181.3M | ||
| Q4 24 | $164.6M | $251.4M | ||
| Q3 24 | $139.5M | $210.2M | ||
| Q2 24 | $147.0M | $192.6M |
| Q1 26 | — | $89.1M | ||
| Q4 25 | $-128.6M | — | ||
| Q3 25 | $-180.4M | $-12.1M | ||
| Q2 25 | $-115.0M | $-11.1M | ||
| Q1 25 | $-151.1M | $-26.2M | ||
| Q4 24 | $-133.2M | — | ||
| Q3 24 | $-133.5M | $-13.4M | ||
| Q2 24 | $-131.6M | $-16.8M |
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
| Q1 26 | — | 37.6% | ||
| Q4 25 | -54.7% | 4.1% | ||
| Q3 25 | -106.9% | 1.3% | ||
| Q2 25 | -64.8% | 1.9% | ||
| Q1 25 | -102.6% | -10.8% | ||
| Q4 24 | -74.3% | 13.2% | ||
| Q3 24 | -94.6% | -0.4% | ||
| Q2 24 | -79.1% | -1.0% |
| Q1 26 | — | 54.8% | ||
| Q4 25 | -62.0% | — | ||
| Q3 25 | -112.8% | -5.6% | ||
| Q2 25 | -69.0% | -5.0% | ||
| Q1 25 | -108.5% | -14.5% | ||
| Q4 24 | -80.9% | — | ||
| Q3 24 | -95.7% | -6.4% | ||
| Q2 24 | -89.5% | -8.7% |
| Q1 26 | — | $0.50 | ||
| Q4 25 | $-1.28 | $0.50 | ||
| Q3 25 | $-1.81 | $-0.07 | ||
| Q2 25 | $-1.17 | $-0.06 | ||
| Q1 25 | $-1.57 | $-0.15 | ||
| Q4 24 | $-1.34 | $0.05 | ||
| Q3 24 | $-1.40 | $-0.08 | ||
| Q2 24 | $-1.52 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $421.0M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-80.0M | $419.1M |
| 总资产 | $1.5B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | $67.6M | ||
| Q4 25 | $421.0M | $96.4M | ||
| Q3 25 | $202.5M | $74.8M | ||
| Q2 25 | $176.3M | $60.5M | ||
| Q1 25 | $127.1M | $71.2M | ||
| Q4 24 | $174.0M | $87.8M | ||
| Q3 24 | $150.6M | $37.2M | ||
| Q2 24 | $480.7M | $64.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
| Q1 26 | — | $419.1M | ||
| Q4 25 | $-80.0M | $449.0M | ||
| Q3 25 | $9.2M | $360.1M | ||
| Q2 25 | $151.3M | $370.4M | ||
| Q1 25 | $144.2M | $381.8M | ||
| Q4 24 | $255.0M | $404.6M | ||
| Q3 24 | $346.8M | $395.5M | ||
| Q2 24 | $432.4M | $405.0M |
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-99.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-100.8M | — |
| 自由现金流率自由现金流/营收 | -48.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-472.0M | — |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $-99.8M | $29.2M | ||
| Q3 25 | $-91.4M | $26.5M | ||
| Q2 25 | $-108.3M | $-795.0K | ||
| Q1 25 | $-166.5M | $-3.5M | ||
| Q4 24 | $-79.3M | $61.8M | ||
| Q3 24 | $-67.0M | $-14.8M | ||
| Q2 24 | $-77.0M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-100.8M | $27.3M | ||
| Q3 25 | $-92.7M | $21.0M | ||
| Q2 25 | $-110.7M | $-6.5M | ||
| Q1 25 | $-167.8M | $-15.7M | ||
| Q4 24 | $-79.5M | $53.8M | ||
| Q3 24 | $-68.6M | $-23.7M | ||
| Q2 24 | $-79.0M | $-12.9M |
| Q1 26 | — | — | ||
| Q4 25 | -48.6% | 12.0% | ||
| Q3 25 | -58.0% | 9.7% | ||
| Q2 25 | -66.5% | -2.9% | ||
| Q1 25 | -120.5% | -8.7% | ||
| Q4 24 | -48.3% | 21.4% | ||
| Q3 24 | -49.2% | -11.3% | ||
| Q2 24 | -53.7% | -6.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 0.9% | ||
| Q3 25 | 0.8% | 2.6% | ||
| Q2 25 | 1.5% | 2.6% | ||
| Q1 25 | 1.0% | 6.7% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | 1.2% | 4.2% | ||
| Q2 24 | 1.4% | 1.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
